News
Feed
Events
Feed
News
+ Events
Feed

Vascular Insights LLC

  • ISIN US9901942279

Latest News

15 October 2012

14:51 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) gibt Dr. Sergio Manuel Martins Da Silva als zertifizierten Schulungsarzt bekannt

14:50 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) gibt Dr. Sergio Manuel Martins Da Silva als zertifizierten Schulungsarzt bekannt

12:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces Dr. Sergio Manuel Martins Da Silva as a Certified Training Physician

12:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces Dr. Sergio Manuel Martins Da Silva as a Certified Training Physician

25 September 2012

14:31 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) kundigt randomisierte klinische Studie zum Vergleich von VNUS ClosureFAST und ClariVein fur Krampfadern an

14:31 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) kündigt randomisierte klinische Studie zum Vergleich von VNUS ClosureFAST und ClariVein für Krampfadern an

24 September 2012

16:33 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces Randomized Clinical Trial Comparing VNUS ClosureFAST With ClariVein for Varicose Vein

16:33 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces Randomized Clinical Trial Comparing VNUS ClosureFAST With ClariVein for Varicose Vein

1 September 2012

00:13 Corporate DE

Vascular Insights LLC

Corporate
DE

Dosisfindungsstudie fur ClariVein(R)

00:13 Corporate DE

Vascular Insights LLC

Corporate
DE

Dosisfindungsstudie für ClariVein(R)

31 August 2012

09:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Dose Finding Trial

09:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Dose Finding Trial

1 August 2012

00:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces 800 Patient Randomized Trial

00:00 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) kundigt randomisierte Studie mit 800 Patienten uber den Vergleich

00:00 Corporate DE

Vascular Insights LLC

Corporate
DE

ClariVein(R) kündigt randomisierte Studie mit 800 Patienten über den Vergleich

00:00 Corporate

Vascular Insights LLC

Corporate

ClariVein(R) Announces 800 Patient Randomized Trial

Upcoming Events

No Events found